vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.
EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($382.1M vs $208.9M, roughly 1.8× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 1.5%, a 1.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -12.5%). EXPRO GROUP HOLDINGS N.V. produced more free cash flow last quarter ($23.2M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -0.2%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Expro is an energy services provider headquartered in Houston, Texas, United States.
IRTC vs XPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $382.1M |
| Net Profit | $5.6M | $5.8M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | 3.1% |
| Net Margin | 2.7% | 1.5% |
| Revenue YoY | 27.1% | -12.5% |
| Net Profit YoY | 518.5% | -74.9% |
| EPS (diluted) | $0.18 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $382.1M | ||
| Q3 25 | $192.9M | $411.4M | ||
| Q2 25 | $186.7M | $422.7M | ||
| Q1 25 | $158.7M | $390.9M | ||
| Q4 24 | $164.3M | $436.8M | ||
| Q3 24 | $147.5M | $422.8M | ||
| Q2 24 | $148.0M | $469.6M | ||
| Q1 24 | $131.9M | $383.5M |
| Q4 25 | $5.6M | $5.8M | ||
| Q3 25 | $-5.2M | $14.0M | ||
| Q2 25 | $-14.2M | $18.0M | ||
| Q1 25 | $-30.7M | $13.9M | ||
| Q4 24 | $-1.3M | $23.0M | ||
| Q3 24 | $-46.2M | $16.3M | ||
| Q2 24 | $-20.1M | $15.3M | ||
| Q1 24 | $-45.7M | $-2.7M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | 3.1% | ||
| Q3 25 | -4.4% | 6.4% | ||
| Q2 25 | -10.0% | 7.7% | ||
| Q1 25 | -20.5% | 2.6% | ||
| Q4 24 | -2.5% | 7.3% | ||
| Q3 24 | -34.1% | 6.2% | ||
| Q2 24 | -15.5% | 5.9% | ||
| Q1 24 | -28.9% | 2.2% |
| Q4 25 | 2.7% | 1.5% | ||
| Q3 25 | -2.7% | 3.4% | ||
| Q2 25 | -7.6% | 4.3% | ||
| Q1 25 | -19.3% | 3.6% | ||
| Q4 24 | -0.8% | 5.3% | ||
| Q3 24 | -31.3% | 3.8% | ||
| Q2 24 | -13.6% | 3.3% | ||
| Q1 24 | -34.6% | -0.7% |
| Q4 25 | $0.18 | $0.05 | ||
| Q3 25 | $-0.16 | $0.12 | ||
| Q2 25 | $-0.44 | $0.16 | ||
| Q1 25 | $-0.97 | $0.12 | ||
| Q4 24 | $-0.03 | $0.20 | ||
| Q3 24 | $-1.48 | $0.14 | ||
| Q2 24 | $-0.65 | $0.13 | ||
| Q1 24 | $-1.47 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $196.1M |
| Total DebtLower is stronger | — | $79.1M |
| Stockholders' EquityBook value | $152.7M | $1.5B |
| Total Assets | $1.0B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $196.1M | ||
| Q3 25 | $565.2M | $197.9M | ||
| Q2 25 | $545.5M | $206.8M | ||
| Q1 25 | $520.6M | $179.3M | ||
| Q4 24 | $535.6M | $183.0M | ||
| Q3 24 | $522.0M | $165.7M | ||
| Q2 24 | $561.5M | $133.5M | ||
| Q1 24 | $569.1M | $163.2M |
| Q4 25 | — | $79.1M | ||
| Q3 25 | — | $99.1M | ||
| Q2 25 | — | $121.1M | ||
| Q1 25 | — | $121.1M | ||
| Q4 24 | — | $121.1M | ||
| Q3 24 | — | $121.1M | ||
| Q2 24 | — | $121.1M | ||
| Q1 24 | — | $40.0M |
| Q4 25 | $152.7M | $1.5B | ||
| Q3 25 | $121.9M | $1.5B | ||
| Q2 25 | $103.7M | $1.5B | ||
| Q1 25 | $86.7M | $1.5B | ||
| Q4 24 | $90.9M | $1.5B | ||
| Q3 24 | $71.8M | $1.5B | ||
| Q2 24 | $99.2M | $1.5B | ||
| Q1 24 | $90.3M | $1.3B |
| Q4 25 | $1.0B | $2.3B | ||
| Q3 25 | $995.2M | $2.3B | ||
| Q2 25 | $964.0M | $2.3B | ||
| Q1 25 | $926.1M | $2.3B | ||
| Q4 24 | $931.4M | $2.3B | ||
| Q3 24 | $909.7M | $2.3B | ||
| Q2 24 | $919.2M | $2.3B | ||
| Q1 24 | $909.8M | $2.0B |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $57.1M |
| Free Cash FlowOCF − Capex | $14.5M | $23.2M |
| FCF MarginFCF / Revenue | 6.9% | 6.1% |
| Capex IntensityCapex / Revenue | 5.6% | 8.9% |
| Cash ConversionOCF / Net Profit | 4.70× | 9.89× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $97.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $57.1M | ||
| Q3 25 | $34.9M | $63.2M | ||
| Q2 25 | $27.7M | $48.4M | ||
| Q1 25 | $-7.9M | $41.5M | ||
| Q4 24 | $19.2M | $97.4M | ||
| Q3 24 | $24.3M | $55.3M | ||
| Q2 24 | $11.8M | $-13.2M | ||
| Q1 24 | $-52.0M | $29.9M |
| Q4 25 | $14.5M | $23.2M | ||
| Q3 25 | $20.1M | $39.0M | ||
| Q2 25 | $17.3M | $27.2M | ||
| Q1 25 | $-17.3M | $8.4M | ||
| Q4 24 | $12.4M | $53.0M | ||
| Q3 24 | $15.5M | $23.3M | ||
| Q2 24 | $3.4M | $-49.5M | ||
| Q1 24 | $-61.8M | $-801.0K |
| Q4 25 | 6.9% | 6.1% | ||
| Q3 25 | 10.4% | 9.5% | ||
| Q2 25 | 9.3% | 6.4% | ||
| Q1 25 | -10.9% | 2.1% | ||
| Q4 24 | 7.5% | 12.1% | ||
| Q3 24 | 10.5% | 5.5% | ||
| Q2 24 | 2.3% | -10.5% | ||
| Q1 24 | -46.8% | -0.2% |
| Q4 25 | 5.6% | 8.9% | ||
| Q3 25 | 7.7% | 5.9% | ||
| Q2 25 | 5.6% | 5.0% | ||
| Q1 25 | 5.9% | 8.5% | ||
| Q4 24 | 4.2% | 10.2% | ||
| Q3 24 | 6.0% | 7.6% | ||
| Q2 24 | 5.7% | 7.7% | ||
| Q1 24 | 7.4% | 8.0% |
| Q4 25 | 4.70× | 9.89× | ||
| Q3 25 | — | 4.52× | ||
| Q2 25 | — | 2.69× | ||
| Q1 25 | — | 2.98× | ||
| Q4 24 | — | 4.23× | ||
| Q3 24 | — | 3.40× | ||
| Q2 24 | — | -0.86× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
XPRO
| NLA | $130.3M | 34% |
| ESSA | $116.3M | 30% |
| MENA | $93.0M | 24% |
| Other | $42.5M | 11% |
